8月11日，卡地纳健康盘中上涨5.78%，报250.89美元/股，成交额1.19亿美元。
消息面上，公司发布财年第四季度业绩：调整后每股收益2.91美元，大幅超越市场一致预期的2.42美元，同比增长约40%；营收636.7亿美元，同比增长5.8%，略低于预期的651.5亿美元。更为关键的是，公司给出的财年前瞻指引调整后EPS为12.40至12.60美元，显著高于FactSet一致预期的12.08美元。与此同时，董事会批准追加50亿美元股票回购授权，为资本回报注入强劲信号。盈利大幅超预期叠加慷慨回购计划，共同推动股价走强。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.